Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cleveland, Ohio 44195


The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of skin cancer excision sites and split thickness skin grafts (STSG). The secondary purpose will be to compare the prospective patients to retrospectively treated skin cancer excision sites and STSGs to further evaluate efficacy and safety.


Inclusion Criteria: - Skin cancer excision site and/or STSG as the source of the wound on any part of the body including head and neck, torso, and extremities. Any other type of skin graft will also be eligible for inclusion into the study. - Wound < 16 cm in greatest diameter - Subject ≥ 18 years of age - Female subjects of child-bearing potential must be willing to take a urine pregnancy test prior to starting study - Subject is willing and able to sign informed consent Exclusion Criteria: - Wound-related cellulitis - Wound located in an area not amenable to forming an air-tight seal - Subject has untreated osteomyelitis - Subject is allergic to wound care products - Wound has exposed blood vessels not suitable for negative pressure therapy - Subject is actively participating in other clinical trials that conflict with current study - Subject has fistulas - Subject is pregnant



Primary Contact:

Principal Investigator
Francis Papay, MD
The Cleveland Clinic

Backup Contact:


Location Contact:

Cleveland, Ohio 44195
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.